Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
about
Recent advances in understanding and managing asthmaAllergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageinAllergen immunotherapy for allergic asthma: a systematic review and meta-analysis.Pathogenic CD4+ T cells in patients with asthma.International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem.Cost utility analysis of the SQ(®) HDM SLIT-tablet in house dust mite allergic asthma patients in a German settingIs allergic sensitization relevant in severe asthma? Which allergens may be culprit?Personalized Medicine in Allergic Asthma: At the Crossroads of Allergen Immunotherapy and "Biologicals"Allergen immunotherapy in allergic rhinitis: current use and future trends.Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents.Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles.Efficacy and safety of SQ house dust mite (HDM) SLIT-tablet treatment of HDM allergic asthma.A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.Immunotherapy in allergic rhinitis and lower airway outcomes.Indoor allergen exposure and asthma outcomes.Allergen immunotherapy: an updated review of safety.Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.Investigational new drugs for allergic rhinitis.MK-8237: a house dust mite vaccine for treating allergic rhinitis, asthma and atopic dermatitis.What Is Wrong with Pertussis Vaccine Immunity? Why Immunological Memory to Pertussis Is Failing.Factor XI deficiency enhances the pulmonary allergic response to house dust mite in mice independent of factor XII.Comparative analysis of the oral mucosae from rodents and non-rodents: Application to the nonclinical evaluation of sublingual immunotherapy productsEffect of adjuvanted and standard sublingual immunotherapy on respiratory function in pure rhinitis due to house dust mite over a 5-year period.Immunotherapy of house dust mite allergy.Comorbid "treatable traits" in difficult asthma: Current evidence and clinical evaluation.Bioavailability of House Dust Mite Allergens in Sublingual Allergy Tablets Is Highly Dependent on the Formulation.Clinical evaluation for sublingual immunotherapy with Dermatophagoides farinae drops in adult patients with allergic asthma.The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma.Mit SLIT weniger Asthmaanfälle.Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid.Immunotherapy, asthma and community allergic reactions to food.Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis.Human Vaccines & Immunotherapeutics: NewsSCIT with a high-dose house dust mite allergoid is well tolerated: safety data from pooled clinical trials and more than 10 years of daily practice analyzed in different subgroupsSublingual allergen immunotherapy for respiratory allergy: a systematic reviewImmunotherapy and Asthma in Children
P2860
Q28077915-1A0D2CA8-7CCF-4BCF-9DDC-5851AD926500Q28077951-FCE15090-1D3C-45DE-87C3-84AE7CD9E740Q30234365-D9A54419-FCB4-48BB-8FB7-ECE31BF1B931Q30252507-CD6CB236-907D-4022-B640-9C1A28E6314BQ33572979-28A14AB2-C009-4D47-BF52-6B47A5F9B55FQ37240207-36CA4285-D422-42C6-BAF8-68ECBB1CC625Q37569401-9B9E4693-EA62-40C5-A407-6F57D79A14BFQ37647767-D282ABC3-2AB6-4562-8302-16FC39E56893Q38680655-38F43DB8-996A-41AC-A4C9-9D39A843BFE7Q38703027-A8A2BBBB-3B08-49B1-BF9B-AA92F5271E12Q38745619-FCBFD57D-6417-468A-965E-10431BD4E5EEQ38870647-A2BCC181-D8D8-47F5-A36C-CD499657F1E0Q38888019-B7988AE8-5642-41C8-A4F2-1FF7253C55E1Q38903486-97BB4FC2-166D-43D1-B1E7-3E3C7D2B79A1Q38960821-86C58E96-524A-4CC9-AB20-8FC39DDA04D0Q39025721-4E73C682-6A0E-4E94-B859-8B49CFC3E42CQ39037216-73A8D2F7-510C-46B7-9343-34FE4A6770A3Q39111947-D4A19EE0-7558-4C8C-ABB7-33B2AF3A56AEQ39399204-64DD09AF-9DBB-45C7-847A-2A15735B7488Q40295966-A7118268-21CD-4458-98F7-65A19A673A16Q40425828-FCDA0DAB-D6D0-4A10-AD46-5CF0CDB8EDE9Q41495360-A3E4A8B6-1818-4B1D-A878-DF6E3BC159C5Q41854493-25744D03-A52C-4624-9CF0-1340739C0CCEQ43915564-B6D3C736-742D-4576-8E14-F4B296A39EA5Q47659621-7BFB82B9-C8A6-441A-AA4B-02FEB1D707DCQ47741028-EE9376B3-9E54-4729-B8D8-CE5B1AD9B4C8Q47743915-B70F1ADA-B38A-4CA0-99C3-A407F2447DF9Q47761576-878931FC-9C88-4B38-A8E2-F414C142A9C4Q47764778-D9061375-1213-400C-AA9C-1012DB65A1ABQ47943200-A75ACF9F-747E-4ED8-B756-4254F864A12FQ50027590-44331BE8-2521-44CB-B152-1243FC1892EBQ50285487-0CB27837-B283-4136-9B29-8E3C34C2C68AQ51517572-12961C6B-7963-4848-82BF-7714615B4CBDQ52841094-CFE335CB-8166-4850-9EAC-E0C6E989A1EAQ56931986-3FE79517-AE9A-4BDE-8C90-0DB005F00313Q57193203-14CA94E3-0557-4409-A393-12B79E51D9A2Q58700135-E0F7825F-340C-46FB-A42B-9CF9BB1A986AQ58729387-CA5881A6-536F-439B-ACC4-1B158F905AFC
P2860
Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Efficacy of a House Dust Mite ...... : A Randomized Clinical Trial.
@en
type
label
Efficacy of a House Dust Mite ...... : A Randomized Clinical Trial.
@en
prefLabel
Efficacy of a House Dust Mite ...... : A Randomized Clinical Trial.
@en
P2093
P356
P1476
Efficacy of a House Dust Mite ...... : A Randomized Clinical Trial.
@en
P2093
Bente Riis
Christian Ljørring
Frederic de Blay
Hanne Hedegaard Villesen
Hendrik Nolte
J Christian Virchow
Luis Prieto
Piotr Kuna
P304
P356
10.1001/JAMA.2016.3964
P407
P577
2016-04-01T00:00:00Z